ADAG Stock Summary and Trading Ideas (Adagene - Ads Each Representing 1.25 | NASDAQ:ADAG)

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Adagene - Ads Each Representing 1.25 trades on the NASDAQ stock market under the symbol ADAG.

As of December 6, 2024, ADAG stock price declined to $2.06 with 84,544 million shares trading.

ADAG has a beta of 0.89, meaning it tends to be less sensitive to market movements. ADAG has a correlation of 0.01 to the broad based SPY ETF.

ADAG has a market cap of $91.20 million. This is considered a Micro Cap stock.

In the last 3 years, ADAG traded as high as $10.88 and as low as $.90.

ADAG has underperformed the market in the last year with a price return of +7.3% while the SPY ETF gained +35.2%. ADAG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.1% and -6.1%, respectively, while the SPY returned +12.8% and +2.1%, respectively.

ADAG support price is $1.95 and resistance is $2.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADAG shares will trade within this expected range on the day.